Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib

J Thorac Oncol. 2018 Nov;13(11):e220-e222. doi: 10.1016/j.jtho.2018.05.035.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Crizotinib / adverse effects*
  • Exons
  • Female
  • Humans
  • Lung Neoplasms / complications*
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology
  • Middle Aged
  • Mutation
  • Oncogene Proteins, Fusion / metabolism*

Substances

  • EML4-ALK fusion protein, human
  • Oncogene Proteins, Fusion
  • Crizotinib